Concepedia

Author

Lee A. Dawson

GlaxoSmithKline (United Kingdom)

Also Known As

Coles, Dawson A Lee, Dawson, L., Dawson, L.A., Dawson, Lee A., L A Dawson, L Dawson, L. A. Dawson, L. Dawson, L.A Dawson

140

Publications

5.1K

Citations

42

H-Index

74

Concepts

All Affiliations

GlaxoSmithKline (United Kingdom)Princeton UniversityWomen's Health Research InstituteGlaxoSmithKline (Italy)Covance (United Kingdom)
LA

About

Lee A. Dawson is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, neuroscience, and neuropharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

30

39

2.6K

2

Social Sciences

25

27

1.9K

3

Biochemistry

3

3

154

4

Health Sciences

2

2

83

5

Engineering

1

1

23

Lee A. Dawson

×

64

Publications

4.3K

Citations

39

H-Index

YearCitations

GSK189254, a Novel H3 Receptor Antagonist That Binds to Histamine H3 Receptors in Alzheimer’s Disease Brain and Improves Cognitive Performance in Preclinical Models

Andrew D. Medhurst, A.R. Atkins, I.J.M. Beresford,

Journal of Pharmacology and Experimental Therapeutics

2007

300

The 5-HT6 Receptor Antagonist SB-271046 Selectively Enhances Excitatory Neurotransmission in the Rat Frontal Cortex and Hippocampus

Lee A. Dawson

Neuropsychopharmacology

2001

237

SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models

Warren D. Hirst, Tania O. Stean, Derek C. Rogers,

European Journal of Pharmacology

2006

228

Neuropharmacological Profile of Novel and Selective 5-HT6 Receptor Agonists: WAY-181187 and WAY-208466

Lee E. Schechter, Qian Lin, Deborah L. Smith,

Neuropsychopharmacology

2007

217

BACE1 (β-secretase) transgenic and knockout mice: identification of neurochemical deficits and behavioral changes

Steve Harrison, Alex Harper, Julie A. Hawkins,

Molecular and Cellular Neuroscience

2003

149

WAY-163909 [(7 bR,10 aR)-1,2,3,4,8,9,10,10 a-Octahydro-7 bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A Novel 5-Hydroxytryptamine 2C Receptor-Selective Agonist with Preclinical Antipsychotic-Like Activity

Karen L. Marquis, Annmarie L. Sabb, Sheree F. Logue,

Journal of Pharmacology and Experimental Therapeutics

2006

145

5‐HT<sub>6</sub> receptor antagonist SB‐271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex

Laurent Lacroix, Lee A. Dawson, Jim J. Hagan,

Synapse

2003

143

α7 and non‐α7 nicotinic acetylcholine receptors modulate dopamine release <i>in vitro</i> and <i>in vivo</i> in the rat prefrontal cortex

Phil D. Livingstone, Srinivasan Jayaraman, James N.C. Kew,

European Journal of Neuroscience

2009

131

Lecozotan (SRA-333): A Selective Serotonin 1A Receptor Antagonist That Enhances the Stimulated Release of Glutamate and Acetylcholine in the Hippocampus and Possesses Cognitive-Enhancing Properties

Lee E. Schechter, Daniel L. Smith, Sharon Rosenzweig‐Lipson,

Journal of Pharmacology and Experimental Therapeutics

2005

130

<i>In vivo</i> effects of the 5‐HT<sub>6</sub> antagonist SB‐271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5‐HT, glutamate and aspartate

Lee A. Dawson, Huy Q. Nguyen, P Li

British Journal of Pharmacology

2000

128

Page 1